Attached files

file filename
8-K - AIR METHODS CORPORATION 8-K 8-1-2011 - AIR METHODS CORPform8-k.htm
EX-10.1 - EXHIBIT 10.1 - AIR METHODS CORPex10_1.htm
EX-99.2 - EXHIBIT 99.2 - AIR METHODS CORPex99_2.htm

Exhibit 99.1
 

The #1 Airborne Healthcare Company

       Air Methods Reports 2Q2011 Results and 3Q2011 Update
      Second Quarter Fully-Diluted EPS of $0.79 In-Line with Previously Announced Expectation

DENVER, CO., August 4, 2011 -- Air Methods Corporation (Nasdaq: AIRM), the largest air medical transportation company in the world, reported financial results for the second quarter ended June 30, 2011 and provided an update on July 2011 community-based patient transports.  For the quarter, revenue increased 8% from $139.2 million to $150.2 million in the current-year quarter.  For the six-month period, revenue increased 9% to $282.1 million, compared with $257.7 million in the prior-year six-month period.
 
For the quarter, net income decreased 21% to $10.1 million, or $0.79 per diluted share, as compared with prior-year second quarter net income of $12.8 million, or $1.02 per diluted share.  Net income for the six-month period increased 25% to $16.1 million, or $1.26 per diluted share, compared to $12.9 million, or $1.03 per diluted share, for the prior-year six-month period.  As previously disclosed, the current-year second quarter results include a pre-tax, non-cash loss of approximately $0.8 million, compared with a loss of $0.1 million in the prior-year quarter, associated with the mark to market of a fuel derivative.  In addition, the current-year quarter includes $0.3 million in transaction costs associated with the recently completed acquisition of OF Air Holdings and its subsidiaries (together, Omniflight).  The current-year quarter also includes a pre-tax loss on disposition of assets of $0.3 million, compared with a pre-tax gain of $0.1 million in the prior-year quarter.  The remaining decrease in quarterly earnings, as compared with the prior-year period, was attributed to lower than anticipated community-based patient transports attributed to higher weather cancellations, and to higher maintenance expenditures.
 
For the second quarter, community-based revenue increased 9% to $94.1 million compared to $86.6 million in the prior year, while segment net income decreased 4% to $19.7 million from $20.4 million.  Total community-based patient transports decreased by 2% to 10,309, as compared with 10,507 in the prior-year quarter.  Community-based patient transports for bases open greater than one year (Same-Base Transports) decreased 6%, or 659 patient transports, as compared with the prior-year quarter.  Weather cancellations for these same base locations increased by 343 compared with the prior-year quarter.  Net revenue per community-based transport was $9,008 for the current-year quarter, compared with $8,181 in the prior-year quarter, a 10% increase.  Hospital-based revenue decreased by 1% to $48.6 million compared to $49.1 million in the prior-year period, while segment net income decreased 61% to $2.0 million from $5.1 million.  External revenue within the Products Division increased $4.0 million, or 112%, compared with the prior-year quarter, while external segment net income increased by 154% to $1.2 million in the current-year quarter. Consolidated maintenance expense increased by $5.5 million or 30%, as compared with the prior-year quarter, despite a 1% decrease in flight volume.  This increase was partially attributed to a $1.2 million increase in aircraft blade replacement costs and lower than average maintenance expenditures experienced in the prior-year quarter.
 
The Company also provided a preliminary update on July 2011 flight volume.  Total community-based transports were 3,856 during July 2011 compared with 3,646 in July 2010, a 6% increase.  Same-Base Transports during the month of July decreased by 14 transports as compared with July 2010, while weather cancellations decreased by 209 as compared with the prior-year month for these same bases.

 
 

 

Aaron Todd, CEO, stated, “We are pleased to have experienced a return to more moderate weather during the month of July.  We are also encouraged that we have been able to achieve healthy growth in net revenue per community-based transport, despite some minor deterioration in payer mix over the past year.  We look forward to the anticipated benefit associated with our recently completed acquisition of Omniflight over future periods.  We have engaged our plan of integration and expect to fully execute this plan over the next six months.  Our financial projections associated with the acquisition continue to be in-line with previously-disclosed expectations.”
 
The Company will discuss these results in a conference call scheduled today at 4:15 p.m. Eastern.  Interested parties can access the call by dialing (877) 883-0656 (domestic) or (706) 643-8826 (international) or by accessing the web cast at www.airmethods.com. A replay of the call will be available at (855) 859-2056 (domestic) or (404) 537-3406 (international), access number 86788278, for 3 days following the call and the web cast can be accessed at www.airmethods.com for 30 days.
 
Air Methods Corporation (www.airmethods.com) is a leader in emergency air medical transportation and medical services. The Hospital Based Services Division is the largest provider of air medical transport services for hospitals. The Community Based Services Division is one of the largest community-based providers of air medical services. The Products Division specializes in the design and manufacture of aeromedical and aerospace technology. The Company's fleet of owned, leased or maintained aircraft features over 300 helicopters and fixed wing aircraft.
 

 
Forward Looking Statements: This news release includes certain forward-looking statements, which are subject to various risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the size, structure and growth of the Company's air medical services and products markets; the collection rates for patient transports; the continuation and/or renewal of air medical service contracts; the acquisition of profitable Products Division contracts and other flight service operations; the successful expansion of the community-based operations; the ability of the Company to successfully integrate Omniflight, the timing of the Omniflight integration and the financial benefits associated with the acquisition of Omniflight; and other matters set forth in the Company's public filings.
 
CONTACTS:  Aaron D. Todd, Chief Executive Officer, (303) 792-7413. Please contact Christine Clarke at (303) 792-7579 to be included on the Company’s fax and/or mailing list.

 
 
– FINANCIAL STATEMENTS ATTACHED –

 
 

 
 
AIR METHODS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
(unaudited)
 
   
June 30, 2011
   
December 31, 2010
 
             
             
ASSETS
           
             
Current assets:
           
Cash and cash equivalents
  $ 43,197       60,710  
Trade receivables, net
    142,011       132,329  
Other current assets
    62,919       45,034  
                 
Total current assets
    248,127       238,073  
                 
Net property and equipment
    212,274       200,875  
Other assets, net
    36,467       35,731  
                 
Total assets
  $ 496,868       474,679  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Current liabilities:
               
Notes payable related to assets held for sale
  $ 11,837       -  
Current portion of indebtedness
    34,431       15,835  
Accounts payable, accrued expenses and other
    57,398       58,217  
                 
Total current liabilities
    103,666       74,052  
                 
Long-term indebtedness
    53,493       81,305  
Other non-current liabilities
    73,827       73,566  
                 
Total liabilities
    230,986       228,923  
                 
Total stockholders' equity
    265,882       245,756  
                 
Total liabilities and stockholders' equity
  $ 496,868       474,679  
 
 
 

 
 
AIR METHODS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands, except share and per share amounts)
(unaudited)
 
   
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
                         
   
2011
   
2010
   
2011
   
2010
 
                         
Revenue:
                       
Flight operations
  $ 140,892       134,326       265,413       247,605  
Product operations
    7,541       3,558       13,342       7,463  
Other
    1,729       1,290       3,312       2,616  
Total revenue
    150,162       139,174       282,067       257,684  
                                 
Expenses:
                               
Operating expenses
    106,216       93,472       202,443       188,892  
Loss (gain) on disposition of assets, net
    335       (81 )     (26 )     (110 )
General and administrative
    18,700       17,021       37,007       32,956  
Depreciation and amortization
    7,058       6,138       13,767       11,733  
      132,309       116,550       253,191       233,471  
                                 
Operating income
    17,853       22,624       28,876       24,213  
                                 
Interest expense
    (1,291 )     (1,626 )     (2,619 )     (3,087 )
Other, net
    73       50       253       88  
                                 
Income before income taxes
    16,635       21,048       26,510       21,214  
                                 
Income tax expense
    (6,552 )     (8,288 )     (10,441 )     (8,351 )
                                 
Net income
  $ 10,083       12,760       16,069       12,863  
                                 
Income per common share:
                               
Basic
  $ 0.80       1.02       1.27       1.03  
Diluted
  $ 0.79       1.02       1.26       1.03  
                                 
Weighted average common shares outstanding - basic
    12,658,641       12,465,266       12,633,222       12,462,444  
Weighted average common shares outstanding - diluted
    12,812,765       12,548,482       12,788,094       12,541,528